Trade Mark Journal No.2026/044 30 October 2026

WO0000001942972 (5)

Office of origin: United States of America

Date of International Registration:14 August 2026
Date of designation in the UK: 14 August 2026
Image for mark 1942972

The mark consists of the word "LUMVOA" with the words "VELIGROTUG-VVZE" in lower case letters below to the left; the letter "O" in "LUMVOA" is depicted as a spoked spiral.

Class 5
Pharmaceutical preparations containing unmodified immunoglobulins for the treatment of eye diseases and conditions; pharmaceutical preparations containing unmodified immunoglobulins for the treatment of immune system related diseases and disorders.

Viridian Therapeutics, Inc.

Representative: Valerie Brennan Plave Koch PLC, 3120 Fairview Park Drive, Suite 420, Falls Church VA 22042, UNITED STATES OF AMERICA